AlphaCentric Advisors LLC

13F filer · CIK 0001913464

Reported Jul 24, 2026

13F portfolio value$118MU.S. long equity reported on 13F

Positions212Not reported new · Not reported closed

Net flow last quarterNot reportedBuys minus sells

Top 10 positions weight16.3%Concentration

Holdings

13F · last 4 quarters free

Scroll for earlier quarters

Company	Value	% of portfolio	% of company	POSITION CHANGE qoq %	First reported
Q2 2026Reported Jul 24, 2026212 positions
GILDGilead Sciences, Inc.	$2.58M	2.19%	0.00%	Not reported	Q2 2020
VRTXVertex Pharmaceuticals Inc / Ma	$2.48M	2.11%	0.00%	Not reported	Q2 2020
INVHInvitation Homes Inc.	$2.21M	1.87%	0.01%	Not reported	Q2 2020
AZNAstrazeneca PLC	$2.16M	1.83%	Not reported	Not reported	Q4 2024
ROIVRoivant Sciences Ltd.	$1.71M	1.45%	0.01%	Not reported	Q3 2023
ARGXArgenx SE	$1.68M	1.42%	0.00%	Not reported	Q2 2020
NBIXNeurocrine Biosciences Inc	$1.64M	1.39%	0.01%	Not reported	Q2 2020
INCYIncyte Corp	$1.64M	1.39%	0.01%	Not reported	Q4 2020
AXSMAxsome Therapeutics, Inc.	$1.6M	1.35%	0.01%	Not reported	Q1 2021
APGEApogee Therapeutics, Inc.	$1.53M	1.30%	0.02%	Not reported	Q3 2024
EEFTEuronet Worldwide, Inc.	$1.46M	1.24%	0.05%	New	Q2 2026
AEVAAeva Technologies, Inc.	$1.44M	1.22%	0.07%	New	Q2 2026
QQQInvesco QQQ Trust, Series 1	$1.37M	1.16%	Not reported	Not reported	Q1 2023
BFSSaul Centers, Inc.	$1.31M	1.11%	0.14%	Not reported	Q4 2024
INSMINSMED Inc	$1.25M	1.06%	0.01%	Not reported	Q2 2020
IONSIonis Pharmaceuticals Inc	$1.22M	1.04%	0.01%	Not reported	Q4 2024
ASNDAscendis Pharma A/S	$1.22M	1.04%	0.01%	New	Q2 2026
PTGXProtagonist Therapeutics, Inc	$1.12M	0.95%	0.01%	Not reported	Q3 2023
BLDRBuilders FirstSource, Inc.	$1.12M	0.95%	0.01%	Not reported	Q4 2021
UMACUnusual Machines, Inc.	$1.12M	0.94%	0.10%	New	Q2 2026
HHHHoward Hughes Holdings Inc.	$1.07M	0.91%	0.03%	New	Q2 2026
PSNLPersonalis, Inc.	$1.06M	0.90%	0.07%	New	Q2 2026
RYTMRhythm Pharmaceuticals, Inc.	$1.05M	0.89%	0.01%	New	Q2 2026
STXSStereotaxis, Inc.	$1.03M	0.87%	0.61%	Not reported	Q2 2020
ROKRockwell Automation, Inc	$990K	0.84%	0.00%	Not reported	Q3 2024
XMTRXometry, Inc.	$965K	0.82%	0.02%	Not reported	Q4 2024
ABBVAbbVie Inc.	$909K	0.77%	0.00%	Not reported	Q2 2020
JAZZJazz Pharmaceuticals plc	$871K	0.74%	0.01%	Not reported	Q2 2020
TEMTempus AI, Inc.	$869K	0.74%	Not reported	New	Q2 2026
PNNTPennantpark Investment Corp	$868K	0.74%	0.38%	New	Q2 2026
AMGNAmgen Inc	$855K	0.72%	0.00%	Not reported	Q4 2022
BIIBBiogen Inc.	$841K	0.71%	0.00%	Not reported	Q2 2020
AHRTAH Realty Trust, Inc.	$814K	0.69%	0.15%	New	Q2 2026
SMASmartStop Self Storage REIT, Inc.	$813K	0.69%	0.05%	New	Q2 2026
RDWRedwire Corp	$795K	0.67%	0.03%	New	Q2 2026
GMEDGlobus Medical Inc	$790K	0.67%	0.01%	Not reported	Q2 2020
CTOCTO Realty Growth, Inc.	$753K	0.64%	0.09%	Not reported	Q4 2024
CPRXCatalyst Pharmaceuticals, Inc.	$742K	0.63%	0.02%	New	Q2 2026
ONDSOndas Inc.	$742K	0.63%	0.02%	New	Q2 2026
AATAmerican Assets Trust, Inc.	$741K	0.63%	0.05%	New	Q2 2026
HALOHalozyme Therapeutics, Inc.	$738K	0.63%	0.01%	New	Q2 2026
MGTXMeiraGTx Holdings plc	$736K	0.62%	0.06%	New	Q2 2026
AXRAmrep Corp.	$733K	0.62%	0.55%	Not reported	Q4 2024
KRYSKrystal Biotech, Inc.	$723K	0.61%	0.01%	Not reported	Q4 2024
MICCMagnum Ice Cream Co N.V.	$696K	0.59%	0.01%	New	Q2 2026
MANHManhattan Associates Inc	$696K	0.59%	0.01%	New	Q2 2026
ISRGIntuitive Surgical Inc	$696K	0.59%	0.00%	Not reported	Q2 2020
AMPXAmprius Technologies, Inc.	$693K	0.59%	0.03%	New	Q2 2026
NUVLNuvalent, Inc.	$686K	0.58%	0.18%	Not reported	Q4 2022
ABVXAbivax S.A.	$685K	0.58%	0.01%	Not reported	Q4 2023

Q4 2024Reported Jan 31, 2025170 positions
LLYELI LILLY & Co	$4.74M	4.73%	0.00%	Not reported	Q2 2020
UNHUnitedhealth Group Inc	$3.6M	3.60%	0.00%	Not reported	Q2 2020
JNJJohnson & Johnson	$2.63M	2.62%	0.00%	Not reported	Q4 2022
ABBVAbbVie Inc.	$2.31M	2.31%	0.00%	Not reported	Q2 2020
MRKMerck & Co., Inc.	$2.25M	2.24%	0.00%	-5.9%	Q2 2020
TMOThermo Fisher Scientific Inc.	$2.17M	2.17%	0.00%	Not reported	Q4 2020
AZNAstrazeneca PLC	$2.08M	2.07%	Not reported	New	Q4 2024
NVONovo Nordisk A S	$2.01M	2.00%	Not reported	New	Q4 2024
GMEDGlobus Medical Inc	$2M	2.00%	0.02%	Not reported	Q2 2020
ISRGIntuitive Surgical Inc	$1.93M	1.93%	0.00%	+196.5%	Q2 2020
LAMRLamar Advertising Co	$1.83M	1.82%	Not reported	New	Q4 2024
BSXBoston Scientific Corp	$1.67M	1.66%	0.00%	Not reported	Q2 2023
PINEAlpine Income Property Trust, Inc.	$1.54M	1.54%	0.63%	New	Q4 2024
NVSNovartis AG	$1.53M	1.53%	0.00%	Not reported	Q2 2020
STXSStereotaxis, Inc.	$1.37M	1.37%	0.71%	Not reported	Q2 2020
VRTXVertex Pharmaceuticals Inc / Ma	$1.25M	1.25%	0.00%	Not reported	Q2 2020
FLNGFlex LNG Ltd.	$1.2M	1.20%	0.10%	New	Q4 2024
BFSSaul Centers, Inc.	$1.16M	1.16%	0.12%	New	Q4 2024
BMYBristol Myers Squibb Co	$1.11M	1.11%	0.00%	Not reported	Q2 2020
SOUNSoundhound Ai, Inc.	$1.09M	1.09%	0.03%	-56.0%	Q2 2023
GPKGraphic Packaging Holding Co	$1.09M	1.08%	0.01%	New	Q4 2024
ABTAbbott Laboratories	$1.06M	1.05%	0.00%	New	Q4 2024
PFEPfizer Inc	$1.03M	1.03%	0.00%	+10.9%	Q2 2020
ELVElevance Health, Inc.	$997K	0.99%	0.00%	Not reported	Q2 2020
GILDGilead Sciences, Inc.	$976K	0.97%	0.00%	+201.8%	Q2 2020
DHRDanaher Corp	$958K	0.96%	0.00%	Not reported	Q4 2020
GNWGenworth Financial Inc	$937K	0.93%	0.03%	New	Q4 2024
BDXBecton Dickinson & Co	$892K	0.89%	0.00%	New	Q4 2024
ATRCAtriCure, Inc.	$796K	0.79%	0.05%	New	Q4 2024
CTOCTO Realty Growth, Inc.	$788K	0.79%	0.13%	New	Q4 2024
VRNAVerona Pharma plc	$753K	0.75%	0.00%	-67.6%	Q3 2022
AXRAmrep Corp.	$719K	0.72%	0.43%	New	Q4 2024
ROKRockwell Automation, Inc	$714K	0.71%	0.00%	+11.1%	Q3 2024
CIMChimera Investment Corp	$700K	0.70%	0.06%	+256.6%	Q2 2021
ARAYAccuray Inc	$693K	0.69%	0.34%	Not reported	Q2 2020
EWEdwards Lifesciences Corp	$691K	0.69%	0.00%	New	Q4 2024
EXKEndeavour Silver Corp	$662K	0.66%	0.00%	-60.7%	Q1 2024
PRCTPROCEPT BioRobotics Corp	$644K	0.64%	0.01%	Not reported	Q3 2021
RKLBRocket Lab Corp	$637K	0.64%	0.01%	+66.7%	Q3 2024
EHCEncompass Health Corp	$635K	0.63%	0.01%	New	Q4 2024
ZBHZimmer Biomet Holdings, Inc.	$623K	0.62%	0.00%	New	Q4 2024
SYKStryker Corp	$619K	0.62%	0.00%	New	Q4 2024
NVDANvidia Corp	$582K	0.58%	0.00%	-27.5%	Q4 2023
SMRTSmartRent, Inc.	$569K	0.57%	0.17%	New	Q4 2024
HOLXHologic Inc	$549K	0.55%	0.00%	New	Q4 2024
CICigna Group	$543K	0.54%	0.00%	Not reported	Q2 2020
XMTRXometry, Inc.	$533K	0.53%	0.03%	New	Q4 2024
CHEChemed Corp	$520K	0.52%	0.01%	New	Q4 2024
NEOGNeogen Corp	$519K	0.52%	0.02%	New	Q4 2024
PFXPhenixFIN Corp	$507K	0.51%	0.51%	New	Q4 2024

Q3 2024Reported Oct 30, 2024180 positions
RITMRithm Capital Corp.	$4.32M	3.21%	0.07%	Not reported	Q2 2021
HRMYHarmony Biosciences Holdings, Inc.	$3.88M	2.88%	0.17%	-20.5%	Q1 2023
LKFTLakefront Biotherapeutics NV	$3.12M	2.32%	0.16%	Not reported	Q4 2020
MRKMerck & Co., Inc.	$2.73M	2.03%	0.00%	Not reported	Q2 2020
EFCEllington Financial Inc.	$2.6M	1.93%	0.22%	Not reported	Q2 2021
NBIXNeurocrine Biosciences Inc	$2.59M	1.93%	0.02%	+221.4%	Q2 2020
MTGMgic Investment Corp	$2.54M	1.89%	0.04%	-13.1%	Q2 2021
ARGXArgenx SE	$2.44M	1.81%	0.01%	-37.9%	Q2 2020
INDVIndivior Pharmaceuticals, Inc.	$2.36M	1.76%	0.18%	New	Q3 2024
DXDynex Capital Inc	$2.32M	1.72%	0.23%	Not reported	Q4 2022
BMRNBiomarin Pharmaceutical Inc	$2.28M	1.70%	0.02%	+97.0%	Q3 2020
SRPTSarepta Therapeutics, Inc.	$2.25M	1.67%	0.02%	+140.0%	Q3 2020
DVAXDynavax Technologies Corp	$2.24M	1.67%	0.15%	+55.0%	Q2 2020
UTHRUNITED THERAPEUTICS Corp	$2.24M	1.66%	0.01%	-56.9%	Q3 2020
RWTRedwood Trust Inc	$2.23M	1.66%	0.22%	Not reported	Q2 2021
FOLDAmicus Therapeutics, Inc.	$2.19M	1.63%	0.07%	+1.2%	Q2 2023
MFAMfa Financial, Inc.	$2.13M	1.59%	0.16%	Not reported	Q2 2021
ATECAlphatec Holdings, Inc.	$2.06M	1.53%	0.26%	New	Q3 2024
EXKEndeavour Silver Corp	$2.04M	1.52%	0.01%	Not reported	Q1 2024
QQQInvesco QQQ Trust, Series 1	$2.04M	1.52%	Not reported	+28.4%	Q1 2023
RPRXRoyalty Pharma plc	$1.91M	1.42%	0.02%	+12.5%	Q4 2023
MIRMMirum Pharmaceuticals, Inc.	$1.76M	1.30%	0.09%	-29.7%	Q4 2023
JAZZJazz Pharmaceuticals plc	$1.73M	1.28%	0.03%	+40.9%	Q2 2020
MITTTPG Mortgage Investment Trust, Inc.	$1.57M	1.17%	0.71%	Not reported	Q2 2023
ACTEnact Holdings, Inc.	$1.54M	1.14%	0.03%	Not reported	Q4 2021
ELSEquity Lifestyle Properties Inc	$1.47M	1.09%	0.01%	Not reported	Q2 2023
ITCIIntra-Cellular Therapies, Inc.	$1.46M	1.09%	0.02%	Not reported	Q3 2020
AMPHAmphastar Pharmaceuticals, Inc.	$1.46M	1.08%	0.06%	+20.0%	Q2 2024
VRNAVerona Pharma plc	$1.44M	1.07%	0.01%	-10.7%	Q3 2022
GSKGSK plc	$1.43M	1.06%	0.00%	Not reported	Q2 2020
APLSApellis Pharmaceuticals, Inc.	$1.37M	1.02%	0.04%	Not reported	Q3 2020
ADAMAdamas Trust, Inc.	$1.27M	0.95%	0.22%	Not reported	Q1 2023
RVNCRevance Therapeutics, Inc.	$1.27M	0.95%	0.23%	Not reported	Q4 2020
ONCBeOne Medicines Ltd.	$1.23M	0.92%	0.00%	-63.3%	Q4 2023
STXSStereotaxis, Inc.	$1.22M	0.91%	0.71%	Not reported	Q2 2020
ENOVEnovis CORP	$1.18M	0.88%	0.05%	+37.5%	Q2 2024
ROIVRoivant Sciences Ltd.	$1.15M	0.86%	0.01%	+13.6%	Q3 2023
GPCRStructure Therapeutics Inc.	$1.14M	0.85%	0.02%	Not reported	Q4 2023
TAKTakeda Pharmaceutical Co Ltd	$1.14M	0.85%	0.01%	Not reported	Q2 2020
PTGXProtagonist Therapeutics, Inc	$1.13M	0.84%	0.04%	Not reported	Q3 2023
CATXPerspective Therapeutics, Inc.	$1.07M	0.79%	0.12%	-2.4%	Q1 2024
CLDXCelldex Therapeutics, Inc.	$1.02M	0.76%	0.05%	-36.8%	Q3 2020
PFEPfizer Inc	$1.01M	0.75%	0.00%	-75.0%	Q2 2020
SNYSanofi	$1.01M	0.75%	0.00%	Not reported	Q4 2021
IMVTImmunovant, Inc.	$998K	0.74%	0.02%	-4.1%	Q2 2020
LNTHLantheus Holdings, Inc.	$988K	0.73%	0.01%	Not reported	Q4 2022
AXSMAxsome Therapeutics, Inc.	$944K	0.70%	0.02%	-30.0%	Q1 2021
KPTIKaryopharm Therapeutics Inc.	$934K	0.69%	0.90%	Not reported	Q4 2020
AGNCAGNC Investment Corp.	$885K	0.66%	0.01%	Not reported	Q3 2022
BCYCBicycle Therapeutics PLC	$849K	0.63%	0.05%	-37.5%	Q3 2023

Q2 2024Reported Jul 25, 2024166 positions
UTHRUNITED THERAPEUTICS Corp	$4.62M	3.40%	0.03%	-9.4%	Q3 2020
BCRXBiocryst Pharmaceuticals Inc	$4.17M	3.07%	0.33%	Not reported	Q4 2021
RITMRithm Capital Corp.	$4.16M	3.06%	0.08%	-9.5%	Q2 2021
PFEPfizer Inc	$3.92M	2.88%	0.00%	-20.0%	Q2 2020
HRMYHarmony Biosciences Holdings, Inc.	$3.68M	2.71%	0.21%	Not reported	Q1 2023
PCRXPacira BioSciences, Inc.	$3.36M	2.48%	0.25%	Not reported	Q4 2022
ARGXArgenx SE	$3.12M	2.30%	0.01%	-9.4%	Q2 2020
LKFTLakefront Biotherapeutics NV	$2.69M	1.98%	0.16%	+3.3%	Q4 2020
MTGMgic Investment Corp	$2.46M	1.82%	0.04%	Not reported	Q2 2021
EFCEllington Financial Inc.	$2.44M	1.79%	0.24%	-9.0%	Q2 2021
MIRMMirum Pharmaceuticals, Inc.	$2.19M	1.61%	0.13%	-31.9%	Q4 2023
DXDynex Capital Inc	$2.17M	1.60%	0.24%	Not reported	Q4 2022
ONCBeOne Medicines Ltd.	$2.14M	1.58%	0.00%	-10.5%	Q4 2023
QUREuniQure N.V.	$2.06M	1.52%	0.94%	Not reported	Q2 2020
FOLDAmicus Therapeutics, Inc.	$2.01M	1.48%	0.07%	+15.7%	Q2 2023
DCGODocGo Inc.	$2.01M	1.48%	0.64%	Not reported	Q4 2022
RWTRedwood Trust Inc	$1.87M	1.38%	0.22%	Not reported	Q2 2021
MFAMfa Financial, Inc.	$1.78M	1.31%	0.16%	Not reported	Q2 2021
CLDXCelldex Therapeutics, Inc.	$1.76M	1.29%	0.07%	+23.4%	Q3 2020
CHRSCoherus Oncology, Inc.	$1.73M	1.27%	0.87%	Not reported	Q2 2020
ACADAcadia Pharmaceuticals Inc	$1.63M	1.20%	0.06%	+122.2%	Q3 2020
AVBPArriVent BioPharma, Inc.	$1.6M	1.17%	0.26%	+3.6%	Q1 2024
RPRXRoyalty Pharma plc	$1.58M	1.17%	0.02%	Not reported	Q4 2023
QQQInvesco QQQ Trust, Series 1	$1.56M	1.15%	Not reported	+188.7%	Q1 2023
DVAXDynavax Technologies Corp	$1.46M	1.08%	0.10%	+6.1%	Q2 2020
MITTTPG Mortgage Investment Trust, Inc.	$1.39M	1.02%	0.71%	Not reported	Q2 2023
MDTMedtronic plc	$1.38M	1.01%	0.00%	-14.6%	Q4 2022
ITCIIntra-Cellular Therapies, Inc.	$1.37M	1.01%	0.02%	Not reported	Q3 2020
BMRNBiomarin Pharmaceutical Inc	$1.36M	1.00%	0.01%	+6.5%	Q3 2020
GSKGSK plc	$1.35M	0.99%	0.00%	Not reported	Q2 2020
ELSEquity Lifestyle Properties Inc	$1.34M	0.99%	0.01%	Not reported	Q2 2023
ACTEnact Holdings, Inc.	$1.3M	0.96%	0.03%	Not reported	Q4 2021
EXKEndeavour Silver Corp	$1.27M	0.93%	0.01%	+3.5%	Q1 2024
BCYCBicycle Therapeutics PLC	$1.21M	0.89%	0.09%	Not reported	Q3 2023
AXSMAxsome Therapeutics, Inc.	$1.21M	0.89%	0.03%	-53.9%	Q1 2021
SNPSSynopsys Inc	$1.19M	0.88%	0.00%	-20.0%	Q2 2020
SRPTSarepta Therapeutics, Inc.	$1.19M	0.87%	0.01%	+2688.1%	Q3 2020
JAZZJazz Pharmaceuticals plc	$1.17M	0.86%	0.02%	+29.4%	Q2 2020
ADAMAdamas Trust, Inc.	$1.17M	0.86%	0.22%	Not reported	Q1 2023
STXSStereotaxis, Inc.	$1.09M	0.80%	0.73%	Not reported	Q2 2020
GPCRStructure Therapeutics Inc.	$1.02M	0.75%	0.02%	-5.5%	Q4 2023
AMPHAmphastar Pharmaceuticals, Inc.	$1M	0.74%	0.05%	New	Q2 2024
KPTIKaryopharm Therapeutics Inc.	$976K	0.72%	0.90%	Not reported	Q4 2020
TRMLTourmaline Bio, Inc.	$965K	0.71%	0.29%	+22.8%	Q1 2024
NBIXNeurocrine Biosciences Inc	$964K	0.71%	0.01%	Not reported	Q2 2020
IMVTImmunovant, Inc.	$964K	0.71%	0.03%	-4.0%	Q2 2020
ROIVRoivant Sciences Ltd.	$930K	0.68%	0.01%	-2.2%	Q3 2023
ENOVEnovis CORP	$904K	0.67%	0.04%	New	Q2 2024
ISRGIntuitive Surgical Inc	$890K	0.66%	0.00%	-33.3%	Q2 2020
VKTXViking Therapeutics, Inc.	$875K	0.64%	0.01%	-8.3%	Q3 2023

Premium opens every quarter this fund has filed